Evidence map›Paper›PMID 35088930›Full record

ArticleHuman brain mapping2022

Deep Bayesian networks for uncertainty estimation and adversarial resistance of white matter hyperintensity segmentation.

Parisa Mojiri Forooshani, Mahdi Biparva, Emmanuel E Ntiri, Joel Ramirez, Lyndon Boone, Melissa F Holmes, Sabrina Adamo, Fuqiang Gao, Miracle Ozzoude, Christopher J M Scott and 17 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 Study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. segcsvdHuman brain mapping · 2026
    Article
  7. Article
  8. Article
  9. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Cerebral small vessel disease lesion segmentation methods: A systematic review.Cerebral circulation - cognition and behavior · 2025
    Review
  15. Free water elimination tractometry for aging brains.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  16. segcsvdHuman brain mapping · 2024
    Article
  17. Article
  18. Article
  19. Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard Aging Brain Study.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 10 institutions in 2 countries.

Parisa Mojiri ForooshaniHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Mahdi BiparvaHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Emmanuel E NtiriHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Joel RamirezHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Lyndon BooneHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Melissa F HolmesHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Sabrina AdamoHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Fuqiang GaoHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Miracle OzzoudeHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Christopher J M ScottHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Dar DowlatshahiDepartment of Medicine, University of Ottawa Brain and Mind Institute, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Jane M Lawrence-DewarThunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada.
Donna KwanDepartment of Psychology, Faculty of Health, York University, Toronto, Ontario, Canada.
Anthony E LangThe Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada.
Karine MarcotteSchool of Speech Pathology and Audiology, University of Montreal, Montreal, Quebec, Canada.
Carol LeonardAudiology and Speech-Language Pathology Program, School of Rehabilitation Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Elizabeth RochonDepartment of Speech-Language Pathology and the Rehabilitation Sciences Institute, University of Toronto, Toronto, Ontario, Canada.
Chris HeynHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Robert BarthaDepartment of Medical Biophysics, Schulich School of Medicine and Dentistry, Robarts Research Institute, Western University, London, Ontario, Canada.
Stephen StrotherDepartment of Medical Biophysics, Rotman Research Institute, Baycrest, University of Toronto, Toronto, Ontario, Canada.
Jean-Claude TardifMontreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.
Sean SymonsDepartment of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Mario MasellisDepartment of Medicine (Neurology Division), Sunnybrook HSC and University of Toronto, Toronto, Ontario, Canada.
Richard H SwartzDepartment of Medicine (Neurology Division), Sunnybrook HSC and University of Toronto, Toronto, Ontario, Canada.
Alan MoodyDepartment of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Sandra E BlackHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Maged GoubranHurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-5880-0818
Sunnybrook Health Science Centre · CAUniversity of Toronto · CAUniversity of Ottawa · CACentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CAMontreal Heart Institute · CAThunder Bay Regional Research Institute · CAToronto Western Hospital · CAUniversity Health Network · CAWestern University · CAYork University · CA

Funding

Canadian Institute for Health Research MOP 13129CIHR 159910CIHR MOP-82744
6 · The paper itself

Abstract

White matter hyperintensities (WMHs) are frequently observed on structural neuroimaging of elderly populations and are associated with cognitive decline and increased risk of dementia. Many existing WMH segmentation algorithms produce suboptimal results in populations with vascular lesions or brain atrophy, or require parameter tuning and are computationally expensive. Additionally, most algorithms do not generate a confidence estimate of segmentation quality, limiting their interpretation. MRI-based segmentation methods are often sensitive to acquisition protocols, scanners, noise-level, and image contrast, failing to generalize to other populations and out-of-distribution datasets. Given these concerns, we propose a novel Bayesian 3D convolutional neural network with a U-Net architecture that automatically segments WMH, provides uncertainty estimates of the segmentation output for quality control, and is robust to changes in acquisition protocols. We also provide a second model to differentiate deep and periventricular WMH. Four hundred thirty-two subjects were recruited to train the CNNs from four multisite imaging studies. A separate test set of 158 subjects was used for evaluation, including an unseen multisite study. We compared our model to two established state-of-the-art techniques (BIANCA and DeepMedic), highlighting its accuracy and efficiency. Our Bayesian 3D U-Net achieved the highest Dice similarity coefficient of 0.89 ± 0.08 and the lowest modified Hausdorff distance of 2.98 ± 4.40 mm. We further validated our models highlighting their robustness on "clinical adversarial cases" simulating data with low signal-to-noise ratio, low resolution, and different contrast (stemming from MRI sequences with different parameters). Our pipeline and models are available at: https://hypermapp3r.readthedocs.io.

Indexed as

LeukoaraiosisWhite MatterAgedBayes TheoremHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingUncertaintyadversarial attacksBayesian neural networksdeep learningimage segmentationuncertainty estimationvascular lesionswhite matter hyperintensity

Identifiers

PMID35088930
PMCPMC8996363
OpenAlexW4221129115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.